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Background: Although unsupported upper extremity exercise (UUEE) is recommended in the
guidelines for pulmonary rehabilitation (PR), it is controversial whether UUEE improves dys-
pnea in patients with COPD. The present study conducted a meta-analysis of randomized
controlled trials to clarify whether UUEE could improve dyspnea in COPD patients.
Methods: A computerized search through PubMed and Embase (up to Mar 2012) was performed
to obtain sample studies. Methodological quality was assessed using the PEDro scale. Weighted
mean differences (WMDs), and 95% confidence intervals (CIs) were calculated and heteroge-
neity was assessed with the I2 test. The overall effect sizes were compared with the minimum
clinically important difference (MCID).
Results: 240 patients from 7 studies were included in this meta-analysis. The mean PEDro score
was 7.0 (SDZ 1.7). The results indicated UUEE relieved dyspnea and arm fatigue during activities
of daily living (ADL) (WMDZ 0.58, 0.55 scores; 95% CIZ 1.13 to 0.02, 1.08 to 0.01),
however, theoverall treatment effectswere lower than theMCID of 1 unit for theBorg scale. There
was no statistical significance for dyspnea and arm fatigue during intervention (WMDZ 0.34,
0.24 scores; 95% CIZ 0.78 to 0.09, 0.33 to 0.81).tive pulmonary disease; ADL, activities of daily living; PR, pulmonary rehabilitation; LEE, lower-
ed upper extremity exercise; RCTs, randomized controlled trials; PEDro, Physiotherapy Evidence
portant difference; WMD, weighted mean difference; CI, confidence interval; HRQL, health-related
nalysis; SUEE, supported upper extremity exercise; CRDQ, chronic respiratory disease questionnaire.
3428 6122.
om (L. Pan).
2 Elsevier Ltd. All rights reserved.
2.08.002
1518 L. Pan et al.Conclusions: UUEE can relieve dyspnea and arm fatigue in patients with COPD during ADL and
should be included in the PR program, however, there is currently a lack of clinical evidence to
support UUEE relieving dyspnea and arm fatigue. Further study is urgent to investigate these
effects of UUEE.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructivepulmonarydisease (COPD) is an important
cause of morbidity and mortality worldwide and results in an
economic and social burden.1,2 As the disease advances, some
patients develop systemic manifestations, exercise intoler-
ance, and peripheral muscle dysfunction.3e5 Dyspnea (e.g.
breathlessness) is one of the most important and debilitating
symptoms in patients with COPD. Progressive dyspnea causes
fatigue and reduces health-related quality of life (HRQL). To
minimize dyspnea and arm fatigue, people with COPD often
reduce the use of their arms during activities of daily living
(ADL) such as cooking, brushing teeth or driving.6 Pulmonary
rehabilitation (PR) programs improve exercise capacity and
reduce both fatigue and dyspnea in patients with COPD.7,8
However, such programs primarily focus on lower-extremity
exercise (LEE) training. The latest evidence-based clinical
practice guidelines and statements on PR recommend that
unsupported upper limb training also should be included in
a comprehensive PR program.7,9 Nevertheless, the role and
effectiveness of unsupported upper extremity exercise
(UUEE) has not been well established.
PR aims to improve quality of life for patients with COPD
by improving functional capacity and reducing dyspnea.
Nowadays, there are published randomized controlled trials
(RCTs) regarding the effect of UUEE on dyspnea. However,
it is controversial whether UUEE improve dyspnea in
patients with COPD. Some published reviews believed that
UUEE could improve arm exercise capacity, but its effect on
dyspnea and arm fatigue remained unclear.10e13 So the
present study undertook a meta-analysis of RCTs to clarify
whether UUEE can improve dyspnea in patients with COPD.
The findings of this meta-analysis maybe offer quantifiable
proof of UUEE relieving dyspnea and guide clinical practice
pertaining to UUEE in individuals with COPD.
Method
Data sources and searches
A computerized search was performed through PubMed and
Embase databases (up to Mar 2012) for original research
articles published in English, Italian and Spanish, using the
following keywords: (COPD OR chronic obstructive pulmo-
nary disease OR chronic obstructive lung disease OR chronic
obstructive airway disease OR emphysema OR chronic
airflow limitation OR chronic airway obstruction) AND (arm
OR upper extremity OR upper limb) AND (exercise therapy
OR exercise OR rehabilitation OR respiratory rehabilitation
OR pulmonary rehabilitation OR physical exercise OR phys-
iotherapy OR physical therapy OR training OR exercise
capacity OR exercise test OR exercise endurance).Bibliographies of all potentially relevant retrieved studies,
identified relevant articles (including unpublished and meta-
analysis studies) and international guidelines were searched
by hand. Finally, 8 RCTs were selected for this meta-analysis
(Fig. 1). Included studies were required to have utilized any
form of outcome measure peculiar to dyspnea during ADL or
intervention, provided that the measurement tool could
demonstrate reliability and validity.
The inclusion criteria were randomized controlled trials
which included:
(1) People with COPD of any age or disease severity, as long
as a formal diagnosis of COPD was based on acceptable
criteria by pulmonary function tests.
(2) This study included any inpatient, outpatient, or home-
based rehabilitation programme of at least 3 weeks
duration that included comparing UEE alone with
a control group and those that compared UEE combined
with LEE with lower extremity training alone.
(3) Primary outcomemeasurewas dyspnea evaluated byBorg
or Borg-modified score14 duringADLandexercise training.
The exclusion criteria were:
(1) Studies including participants with healthy age-
matched and gender-matched control subjects and
other respiratory conditions such as asthma, bronchi-
ectasis, interstitial lung disease and cystic fibrosis.
(2) Studies that PR programs did not include UEE or quan-
tify arm performance with other outcome measures
except dyspnea.Data extraction and quality assessment
To assess eligibility, data and trial quality information from
the papers selected for inclusion in the meta-analysis were
extracted independently by two investigators (WX Zhang and
J Sun). A third investigator (JH Yan) was consulted in case of
disagreement to improve accuracy. The analytical data
missing from the primary reports were requested from their
authors. Methodological quality of the trials was assessed
using the PEDro scale.15 Two investigators rated each study
independently and assigned amaximum score out of 10. This
study followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement.16
Data analysis
All data were combined using STATA version 11.0 (Stata
Corporation, College Station, Texas, USA). For continuous
outcomes (e.g. dyspnea and arm fatigue score), a mean
Figure 1 Search strategy and flow chart of screened, excluded, and eventually analyzed articles. RCTZ randomized controlled
trial.
Upper extremity exercise improving dyspnea 1519difference was calculated using weighted mean difference
(WMD) in this study.Homogeneity among studieswas tested.17
Heterogeneity across studies was tested by using the I2
statistic, which was a quantitative measure of inconsistency
across studies. Studies with an I2 statistic of 25%e50% were
considered to have low heterogeneity, those with an I2
statistic of 50%e75% were considered to have moderate
heterogeneity, and those with an I2 statistic of >75% were
considered to have a high degree of heterogeneity.18 The
effect sizes were weighted by the inverse of the population
variance and combined with a fixed-effect model when there
was low heterogeneity (I2< 50%). Otherwise a random-effect
model was used to perform statistical analysis. Subgroup
analysis with rejecting the large-heterogeneity trial to
provide biased results, was indicated when significant
heterogeneity was found among the primary findings of the
trials. An assessment of publication biaswas desirable but not
feasible with the limited number of studies in this study.
Whenever possible, the overall treatment effect was
compared with its minimum clinically important difference
(MCID). The MCID for Borg scores was set at 1 score.19Results
Bibliographic search results
A total of 316 potential studies were retrieved from the
computer searches. Following screening of study titles and
abstracts, 229 articles were considered to be unrelated to
the aims of the study. 87 potentially relevant studiesidentified for full-text analysis, 80 studies were excluded.
Reasons for exclusion are presented in Fig. 1. Finally, 7
RCTs20e26 were selected for this meta-analysis, and only 1
RCT21 was published in non-English.
Characteristics of the included trials
Table 1, included 7 trials, shows important demographic and
clinical characteristics of the patients in each trial. Most
patients were elderly and had moderate to severe COPD.
These studies were published between 1988 and 2012. The
sample size of the RCT ranged from 22 to 50 (total 240).
However, gender and age of distribution between treatment
and control groups was not stated in only one trial, other 6
trials including 136 males and 76 females. Overall, duration
of UEE program lasted 3e8 weeks and exercise time lasted
20e40 min, however, only 3 studies mentioned exercise
time.21,23,26 In addition, most of the RCTs took the increased
resistance arm training except only 1 RCT22 taking the
incremental upper limb endurance training mode. All of the
selected trials included detailed characteristics of the UEE
Programs in Table 1 and the outcome data of each included
trial are described in Table 2.
Studies which investigated the upper extremity exercise
were subdivided into supported upper extremity exercise
(SUEE) or unsupported upper extremity exercise (UUEE)
according to whether the weight of the arm was supported
or unsupported. In this study, the major upper extremity
exercise model of the incorporation of RCTs was UUEE
except one trial26 combining SUEE and UUEE. Hence, UEE
meant or represented UUEE in this meta-analysis.
Table 1 Characteristics of randomized controlled trials included in the meta-analysis.
Study, Year Patients No.
(M/F);
grade
Study group (n) Intervention (i.e. UAE; UEET; ATP) group Control group
Design/Measurement
mode
Assessing
dyspnea
Duration
(weeks)/Exercise
time
Frequency
(days/week)
Intervention
Ries et al,
198820
28 (NA);
moderate to
severe
UAE-GR (8)UAE-
PNF (9)
Control (11)
UAE: Arm ergometry;
GR: 5 low resistance high
repetition exercises;
PNF: 3 progressive
resistance training with
free weights/UULET; the
simulated ADL test
Borg-m 8/NA Every other day
for one week;
then once daily
Walking training
Sivori et al,
199821
28 (23/5);
severe
UEET (14)
LEET (14)
UUEET/the endurance
test
Borg 8/20 min 3 Lower limb training
Holland et al,
200422
38 (24/14);
severe to very
severe
UAE (22)
Control (16)
Incremental unsupported
upper limb endurance
training/UULET
Borg-m 6/NA 7 Lower limb endurance
training.
Marrara et al,
200823
22 (12/10);
severe’
UAE (8)
LL (8)
Control (6)
UUEET (elbow flexion;
elbow extension;
primitive diagonal;
functional diagonal;
inclined supine)/
standard daily physical
activities test
Borg-m 6/30 min 3 Control: bronchial
hygiene therapy; LL
aero: treadmill
Costi et al,
200924
50 (33/17);
moderate to
severe
UEET (25)
Control (25)
UUEET: 15 sessions of
resistance exercises
using
Dumbbells/6MRT;
standard ADL field test
Borg-m 3/NA 7 Lower extremities and
general exercises.
Janaudis-
Ferreira
et al, 201125
36 (21/15);
severe
ATP (17)
Control (19)
Unsupported ATP: 18
sessions of increased
resistance arm training
with freeweights/UULET;
6PBRT; identical work
level; ADL
Borg 6/NA 3 Sham training consisted
of upper limb flexibility
and stretching exercises
McKeough
et al, 201226
38 (23/15);
moderate
Strength (9)
Endurance (11)
Combined (9)
Control (9)
Arm endurance
(supported and
unsupported) and
strength (unsupported)
training/endurance arm
crank test (identical
work rate used); UULET
Borg-m 8/20 min 3 Standard leg endurance
and strength training
M/F: Male/Female; NA: not applicable; UAE: unsupported arm exercise; GR: gravity resisted exercise; PNF: proprioceptive neuromuscular facilitation exercise; Borg-m: modified Borg
dyspnea scale; LL: lower limbs; aero: aerobic/endurance training; Borg: Borg dyspnea scale; BFS: Breathlessness and Fatigue Scale; UUEET: unsupported upper extremity exercise training;
LEET: lower extremity exercise training; 6MRT: 6-min ring test; ADL: activities of daily living; ATP: arm training program; UULET: unsupported upper limb exercise test; 6PBRT: 6-min
pegboard and ring test.
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Table 2 Outcome data of studies included in the meta-analysis (Experimental versus Control).
Study, Year Patients No. Dyspnea (scores) Arm fatigue (scores)
ADL Intervention ADL Intervention
Ries et al, 198820 17 vs. 11 0.02  0.43
vs. 0.4  1.9
1.15  1.75
vs. 1.4  2.3
0.09  1.58
vs.-0.1  1.78
0.91  1.61
vs. 0.7  2.5
Sivori et al, 199821 14 vs. 14 NR 1.71  1.66
vs. 0.35  1.68
NR NR
Holland et al, 200422 22 vs. 16 NR 0.29  2.22
vs. 0.13  2.17
NR NR
Marrara et al, 200823 8 vs. 6 0.1  1.04
vs. 0.4  0.89
NR NR NR
Costi et al, 200924 25 vs. 25 1.24  1.8
vs. 0.51  1.1
0.7  1.1
vs. 0.34  1
0.74  0.9
vs. 0.08  1.2
0.16  1.5
vs. 0.5  1
Janaudis-Ferreira
et al, 201125
17 vs. 19 NR 0.4  2
vs. 12.1
NR 0  2.14
vs. 11.82
McKeough
et al, 201226
29 vs. 9 NR 0.31  2.76
vs. 0.7  3.29
NR 0.07  2.37
vs. 1.4  2.86
NR: not reported; ADL: activities of daily living.
Upper extremity exercise improving dyspnea 1521Quality assessment of the included trials
Two investigators (WX Zhang and J Sun) agreed on every
item of the PEDro scores. Individual scores attributed to
each aspect of the PEDro scale, by both assessors, are
summarized in Table 3. The mean PEDro score of the 7 trials
was 7.0 (SD Z 1.7).Meta-analyses of outcome measures
In this meta-analysis, dyspnea and arm fatigue were
assessed by the Borg (or modified Borg). In total, 7 RCTsTable 3 Quality score of selected trials by the PEDro.
Study, Year Random
allocation
Concealed
location
Baseline
similar
Blinding
(subject)
Blindin
(thera
Ries et al,
198820
O  O  
Sivori et al,
199821
O  O  
Holland et al,
200422
O  O O 
Marrara
et al, 200823
O  O  
Costi et al,
200924
O O O O O
Janaudis
-Ferreira
et al, 201125
O O O O 
McKeough
et al, 201226
O O O  
Mean
 SD score
Note: ITT Z Intention-to-treat analysis; O Z PEDro criteria met;  Zwere included in 4 separate meta-analyses (Figs. 2e5), with
the effect size being interpreted descriptively using WMD.
Dyspnea during ADL and intervention
During ADL, three studies20,23,24 were combined in a fixed
effects meta-analysis model because there was no evidence
of between-study heterogeneity in treatment effect (p for
heterogeneity Z 0.875; I2 Z 0.0%). The pooled meta-
analysis result indicated that there was a statistical
difference between the intervention group and the control
group (WMDZ 0.58; 95% CIZ 1.13 to 0.02; pZ 0.043)
(Fig. 2). However, the overall treatment effect was lowerg
pist)
Blinding
(assessor)
Measures
for >85%
ITT Group
comparison
Point
measures
Total
score
  O O O 5
 O O O O 6
O O O O O 8
  O O O 5
 O O O O 9
O O O O O 9
O  O O O 7
7.0
 1.7
PEDro criteria not met.
Figure 2 A Forest plot of the meta-analysis of 3 studies comparing unsupported upper extremity exercise with control for change
in dyspnea during activities of daily living. The weight (or influence) of the study is calculated by STATA version 11.0. Each block
represents a study and the area of each block is proportional to the precision of the mean treatment effect in that study. The
horizontal line represents each study’s 95% confidence interval (CI) for the treatment effect. The centre of the diamond is the
average treatment effect across studies, and the width of the diamond denotes its 95% CI.
1522 L. Pan et al.than the MCID of the Borg scale compared with 1 score.
There were 6 trials20e22,24e26 measuring pre- and post-
intervention dyspnea change in this meta-analysis. These
studies were combined in a fixed effect model since there
was small heterogeneity of between-study in treatment
effect (p for heterogeneityZ 0.410; I2Z 0.9%). The pooled
result showed no statistical difference between the inter-
vention group and the control group (WMD Z 0.34; 95%
CI Z 0.78 to 0.09; p Z 0.124) (Fig. 3).Arm fatigue during ADL and intervention
Two trials20,24 were conducted a meta-analysis on arm
fatigue during ADL using a fixed effects meta-analysis
model without heterogeneity in treatment effect (p for
heterogeneity Z 0.355; I2 Z 0.0%). The result indicated
that there was a statistical difference between the two
groups (WMD Z 0.55; 95% CI Z 1.08 to 0.01;
p Z 0.046) (Fig. 4). However, the overall treatment effect
was lower than the MCID of the Borg scale compared with 1
score. Four trials20,24e26 were conducted a meta-analysis on
arm fatigue during intervention using a fixed effects meta-
analysis model because of the minimal heterogeneity in
treatment effect (p for heterogeneity Z 0.252;
I2Z 26.6%). The pooled meta-analysis result indicated thatFigure 3 A Forest plot of the meta-analysis of 6 studies comparin
in dyspnea during intervention. See Fig. 2 legend for explanation othere was no difference between the two groups
(WMDZ 0.24; 95% CIZ 0.33 to 0.81; pZ 0.407) (Fig. 5).Discussion
Qualitative findings
The results of meta-analysis suggest that UUEE can relieve
dyspnea and arm fatigue in patients with COPD during ADL
and should be included in the PR program, however, there
is currently a lack of clinical evidence to support UUEE
relieving dyspnea and arm fatigue. So, whether can UUEE
relieve dyspnea clinically in patients with COPD remains
still unclear. Further larger-sample clinical trials are
a priority needed to substantiate the current findings and
investigate the long-term effects of UUEE.
Practice implications
Dyspnea is a primary symptom of COPD and an important
outcome measure for PR. Numerous standardized measures
have been developed to evaluate dyspnea and are being
used increasingly in clinical trials. The MCID is not well-
defined for these measures but is important in interpretingg unsupported upper extremity exercise with control for change
f symbols used.
Figure 4 A Forest plot of the meta-analysis of 2 studies comparing unsupported upper extremity exercise with control for change
in arm fatigue during activities of daily living. See Fig. 2 legend for explanation of symbols used.
Upper extremity exercise improving dyspnea 1523the clinical meaning of results of studies in this area.19 Any
amount of change is greater than the MCID threshold is
reckoned to be meaningful or important.27
The results showed that there was a statistical difference
between the intervention group and the control group on
dyspnea and arm fatigue during ADL, that is to say the scores
of the intervention groupwere significantly less than those in
the control group. This finding is in keeping with positive
improvements in dyspnea correlating with negative Borg
scores, which suggest UUEE may reduce dyspnea and arm
fatigue during ADL in patients with COPD. Multiple mecha-
nisms are accounting for UUEE reducing dyspnea. UUEE
improved auxiliary respiratorymuscle endurance andmuscle
strength and increased thoracic muscles and expansion of
the rib cage resulting in the diaphragm being in a better
position to play a better role,28 and modulated dynamic
hyperinflation.29 Moreover, the accessory muscles assisted
with the postural support of the arm diminishing their
participation in ventilation and the respiratory work to the
diaphragm.30,31 However, dyspnea or fatigue changes in Borg
ratings pre-and postintervention were lower than the MCID
of 1 score, which shows that these changes are not clinically
important difference. In addition, there was no statistical
difference on dyspnea and arm fatigue during intervention
between the two groups. Considering that the most appro-
priate way to evaluate whether or not the intervention
impacted dyspnea and arm fatigue is to compare them at iso-
work, 3 RCTs20,23,24 comparing outcomemeasures during ADL
were believed at iso-work due to the standard ADL field test.
However, only 2 RCTs25,26 compared outcome measuresFigure 5 A Forest plot of the meta-analysis of 4 studies comparing
in arm fatigue during intervention. See Fig. 2 legend for explanatiduring intervention at identical work level. Hence, itmust be
extremely cautious about this finding, and the present study
did not draw a conclusion that therewas ineffective for UUEE
improving dyspnea and arm fatigue during intervention in
patients with COPD in clinics.
In addition, there is no consensus of opinion regarding the
duration of the PR intervention.7,9 No clinical trials have
focused on the impact of program duration on arm training
outcomes. In the present study, although duration of UUEE
program lasted only 3e8 weeks, the results indicated UUEE
can improve dyspnea and arm fatigue during ADL, which
suggests that short UUEE programduration of 8weeks has the
potential effects to reduce symptoms in patients with COPD.
However, further research is required to investigate these.Limitations
Some limitations of this study should be taken into account.
Firstly, the present meta-analysis includes a small number of
studies (nZ 7) involving small numbers of participants (range
8e25 per intervention group). Overestimation of the treat-
ment effect is more likely in smaller trials compared with
larger samples. Secondly, these trials ranged from 3 to 8
weeks in length,with participants training from3 days aweek
to daily. The possibility that the samples were heterogeneous
coupled with the diverse UUEE protocols, may limit the reli-
ability of the results. Finally, retrieval of conference
proceedings, unpublished studies was not undertaken, which
created the potential for publication bias.unsupported upper extremity exercise with control for change
on of symbols used.
1524 L. Pan et al.Conclusions
Despite such limitations, the findings suggest that UUEE
can improve dyspnea and arm fatigue during ADL in
patients with COPD and should be included in the PR
program. Further larger-sample RCTs with standardized
training methodology are a priority needed to examine the
effects of clinical outcome measures, and should pay more
attention to determine the clinical significance and
compare dyspnea and arm fatigue with iso-work. Addi-
tional studies need to focus on the best type of UEE
because most studies are lacking of other types of training
(e.g. endurance vs. resistance, supported vs. unsup-
ported). Research on the field is worthwhile and should be
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